Milestone Pharmaceuticals (MIST) Receivables - Other (2018 - 2026)

Milestone Pharmaceuticals' Receivables - Other history runs 9 years deep, the most recent figure standing at $1.2 million for Q1 2026.

• Quarterly Receivables - Other rose 1.97% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 1.97% YoY) and the FY2025 annual result came in at $1.6 million, up 195.81% from the prior year.
• Receivables - Other was $1.2 million for Q1 2026 at Milestone Pharmaceuticals, up from $946000.0 in the prior quarter.
• Across five years, Receivables - Other topped out at $1.7 million in Q4 2023 and bottomed at -$1.8 million in Q1 2024.
• A 5-year average of $668058.8 and a median of $694000.0 in 2023 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2022 — Receivables - Other soared 1076.32% — and 2024, when it plunged 358.65%.
• Milestone Pharmaceuticals' Receivables - Other stood at $447000.0 in 2022, then jumped by 277.4% to $1.7 million in 2023, then tumbled by 83.46% to $279000.0 in 2024, then soared by 239.07% to $946000.0 in 2025, then climbed by 25.79% to $1.2 million in 2026.
• Business Quant data shows MIST's Receivables - Other at $1.2 million in Q1 2026, $946000.0 in Q4 2025, and $398000.0 in Q3 2025.